United States-based STI Pharma LLC announced yesterday that it has named Frank Mullery as its new president and CCO.
Mullery has more than 15 years of experience in the pharmaceutical industry, most recently serving as the president, Institutional Business at Mylan Inc, from 2016 to 2019. Prior to this, Mullery was CFO of North America for Mylan and has held roles of increasing scope and complexity in both the commercial and financial functions for Teva Pharmaceuticals and Viropharma Inc.
In his new role at STI Pharma, he will report directly to Anup Dam, chairman and manager of STI Pharma.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer